TTX-030 | m-entrepreneurship.com

Product Name :
TTX-030

Search keywords :
CD39

drugId :
null

Target Vo:
Ectonucleoside triphosphate diphosphohydrolase 1

Target Vo Short Name :
CD39

Moa_Name:
Ectonucleoside triphosphate diphosphohydrolase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Adimab LLC

Active Company_Name :
Abbvie Inc

Active Indication_Name:
Pancreatic Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JAK2 Antibody (YA721)
ATF6 Antibody (YA604)
Clenbuterol Antibody (YA904): Clenbuterol Antibody (YA904) is an unconjugated, rabbit-derived, anti-Clenbuterol (YA904) monoclonal antibody. Clenbuterol Antibody (YA904) can be used for: ELISA expriments in background without labeling.

Author: Betaine hydrochloride

Related Posts